The use of PET imaging in non-small cell lung cancer patients reduced the number of unnecessary surgeries by 50 percent.

Could PET/MR be a better modality than conventional MR and CT for bladder cancer?

Insufficient evidence proving benefit of Alzheimer’s drug Amyvid behind Medicare’s ruling to limit or deny coverage.

Clinicians using 18F-FDG PET on patients with cervical spinal cord compression may be able to predict an improved outcome after surgical decompression.

Nuclear medicine and MR technologists recommend regulations around education, certification and staffing for the new hybrid technology.

The promise of PET/MRI is clear, but challenges remain when it comes to implementing, reading and billing the new technology. This is the second in a two-part series.

The institutions that adopted PET/MRI after its 2011 approval reflect on the changes in workflow and protocol, and the utility and future of the new technology. This is the first in a two-part series.


Subscribe to
Please Wait 20 seconds or click here to close